ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases

Bioresorbable vascular scaffolds (BVS) have the potential to start new era in interventional cardiology. First clinical studies in stable coronary artery disease have demonstrated a good safety profile and promising results. The use of BVS in ST elevation myocardial infarction (STEMI) has not yet been reported. The first two implantations of BVS Absorb® during primary PCI for STEMI in humans performed at our institution in December 2012 are described. Both patients have given written informed consent. The first patient, a 54-year-old male, …